I am pleased to present Vol. 2, Issue 2, 2010, of the Journal of Pharmacy and Bioallied Sciences that encompasses peer-reviewed articles, which reflect the recent developments in the frontiers of pharmaceutical sciences, medicinal chemistry, biotechnology, and bioallied sciences, which will update the analytical attributes of researchers, scientists, and academicians for real time applications and will serve as an excellent source of material for future studies. Articles published in JPBS are now abstracted and indexed by the major indexing media including Caspur, DOAJ, EBSCO Publishing\'s Electronic Databases, Genamics Journal Seek, Google Scholar, Health and Wellness Research Center, Health Reference Center Academic, Hinari, Index Copernicus, Open J-Gate, SCOLOAR, SIIC databases, Ulrich\'s International Periodical Directory, and so on.

In this multifaceted endeavor, I appreciate the efforts and hard work of the authors and reviewers, whose overwhelming responses have hard pressed our editorial team to work diligently toward the timely delivery of this issue. I also appreciate the support of subscribers and readers whose enthusiasm and feedback have provided us triggers to strive for excellence in context, to enable JPBS to rise to the greatest heights.

With burgeoning interest in new avenues and the changing scenario in molecular biological sciences and drug design technology, singlet chemistry has become an interdisciplinary subject, broadening the borderlands between chemistry, pharmacokinetics, biopharmaceutics, pharmacology, toxicology, genetics, computer modeling, bioallied sciences, and the like.

All this has reaffirmed the pivotal role of synthesis based on the structure details of target sites, which is possible by structural biology. With the advent of technological development, which includes magnets with powerful field strength, high-power radiation sources, faster computer chips, and internet-based application, manipulation of the drug designing processes can be done in a better and more efficient way. Such knowledge, coupled with the power of high speed functional screening processes, will provide us new solutions. I look forward to more contributions from researchers and scholars in these latest areas, focused on target structures that promote a new insight into the functional aspects of many disease molecules. However, we endeavor to cover research articles and reviews on various aspects of the current new drug discovery research, such as, Quantitative structure-activity relationship (QSAR), 3-D QSAR, Computer aided drug designing, prodrugs, combinatorial chemistry, bioinformatics, as well as green chemistry, which includes the use of microwaves, phase transfer catalysis, sonochemistry, and so on. Our official website is [www.jpbsonline.org](www.jpbsonline.org) and online submission of manuscripts is available at [www.journalonweb.com/jpbs](www.journalonweb.com/jpbs). We also request institutions to subscribe to JPBS for their libraries, so that JPBS can be easily accessed by students and researchers. The subscription information is available at [www.jpbsonline.org/subscribe.asp](www.jpbsonline.org/subscribe.asp).

I wish and hope that this issue of JPBS will meet the expectations of our upcoming talents, open new vistas of knowledge and information, and promote research in new avenues of pharmacy and bioallied sciences.
